Healthy VolunteersBehavior and Behavior Mechanisms
Investigational drug(s) / intervention(s)
Neurophysiological measure (EEG)Survey
Neurophysiological measure (EEG): Cerebral electric activity recorded with EEG
Survey: Participants complete a survey to evaluate their exposure to screens and their assessment of the laboratory task performed
Study summary
The aim of this study is to validate a new hybrid (ecological + virtual) decision-making tool. The difference in behavior (risky choices) between the "hybrid" task and the "virtual" task will be evaluated.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Men and women aged 18 to 65 inclusive
* Subjects with no neurological or psychiatric disorders
* Subjects with no addictive disorder except tobacco
* Signed informed consent indicating that the subject has understood the purpose and procedures of the study and agrees to participate in the study and to abide by the requirements and restrictions inherent in the study
* Affiliation with a French social security scheme or beneficiary of such a scheme.
Exclusion Criteria:
* Men and women under 18 or over 65 years of age
* Subjects suffering from a neurological or psychiatric disorder
* Subjects suffering from an addictive disorder, with the exception of tobacco
* Legal incapacity or limited legal capacity
* Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
* Subject without health insurance
* Pregnant
* Subject within the exclusion period of another study or on the "national volunteer list".
Primary outcome measure(s)
Validation of the homemade "Lab-Life" interface as a tool for simulating an ecological task with sufficient fidelity, while meeting the conditions required for recording high-quality brain activity using an EEG-HR. — Day 1 Behavioral score obtained after completion of the hybrid task (netscore obtained at the IGT). This score can be compared with the scores obtained after the ecological and virtual tasks.
Trial sites (1)
Facility
City
Region
Status
CHU Besançon
Besançon
Not in US/Canada
Recruiting
More Centre Hospitalier Universitaire de Besancon trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
